Welcome to the Trial Talks podcast, a thought-provoking show about clinical research. On this podcast, we will be exploring trends in the industry as well as the changing landscape, pandemic impact, various types of research, and more.
Today, I’ll be talking with Donna Chang, the CEO and founder of Hope Biosciences. Hope Biosciences focuses on stem cell research to prevent disease and degeneration. In this episode we will be talking about the progress that has been made in the last decade, with regards to stem cell research. We’ll also be talking about stem cell research and COVID-19.
Talking Points:
Resources/Links:
Official website: Hope Biosciences
With the rise of decentralized trials comes a focus on patient-centricity, but what does that look like holistically? Trishna Bharadia joins us to discuss...
Due to COVID-19 the clinical trial industry has been adopting advanced clinical trial technology at warp speed, but what does this mean for the...
Patients are no longer passive research subjects, but rather being integrated into the research process from the start. Patient advocates help with such integrations,...